Mattia Garutti, MD, discusses the potential shift to neoadjuvant therapy in melanoma.
Mattia Garutti, MD
Advertisement
Articles by Mattia Garutti, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA CTGTAC Votes in Favor of RP1/Nivolumab Data in Advanced Melanoma
2
Dr Barot on the FDA Approval of Palbociclib/Trastuzumab ± Pertuzumab in HER2+ Breast Cancer
3
Dr Galsky on Data Supporting the FDA Approval of Perioperative EV/Pembrolizumab in MIBC
4
European Commission Approves First-Line Dato-DXd for Immunotherapy-Ineligible Metastatic TNBC
5